挪威OTC藥品市場 是由出版商Euromonitor International在2009年06月所出版的。
這份英文市場調查報告書包含Tables: 121 價格從美金2400起跳。
Abstract
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive
environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products;
Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies;
Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated
skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans;
Vitamins and dietary supplements; Wound treatments
Executive summary
OTC healthcare market characterised by preventative and simple remedies
In 2008 vitamins and dietary supplements accounted for half of value sales
followed by analgesics. The importance of these two product groups reflects
two dominant trends in Norwegian healthcare. Strong value sales of vitamins
and dietary supplements are underpinned by a "back to basics" philosophy of
healthcare, in which Norwegians are encouraged to be responsible for their own
well-being through exercise and good nutrition. Norwegians consume vitamins
and dietary supplements to help prevent illness. The popularity of analgesics
underlines the simple approach of many Norwegians. Analgesics such as the
bestselling are familiar, multifunctional products suitable for many age
groups. In general, Norwegians prefer Paracet to a multitude of highly
segmented remedies.
Marketing plays critical role in selling products
Brand dynamics are of increasing importance, as OTC healthcare products are
more widely distributed through mass retail outlets due to the recent
liberalisation of distribution laws. The three leading suppliers all offer
well recognised brands, such as Pepcid Duo, Paracet, Pamol, Zymelin, Imodium,
Nicorette, Lamisil and Nicotinell. A greater number of suppliers are investing
in building brands in product areas that were previously anonymous, such as
McNeil' s TV campaign for the Pepcid Duo H2 blocker.
Fragmentation characterises competitive environment
The competitive environment for OTC healthcare is characterised by many
players holding small value shares. Three Norwegian companies, Nycomed Pharma
AS, Axellus AS (Orkla) and Weifa AS, are the leading suppliers of OTC
medicines and nutritionals in Norway. The major multinationals, including
Novartis, Pfizer and McNeil, are present in OTC healthcare in Norway with
smaller value shares. Many smaller Norwegian companies, including Vesterålens
Naturprodukter and VitaePro, are competing in nutritionals. The fragmentation
of suppliers is a direct contrast to the highly consolidated pharmacy and
grocery channels through which the products are distributed.
Pharmacies develop loyal and satisfied customer base
Pharmacies in Norway have loyal and satisfied customers. In a customer
satisfaction survey called Kundebarometer, Norwegians ranked all the pharmacy
chains within the top 20% of Norwegian companies in terms of satisfaction and
loyalty. The two leading chains -- Alliance Apotek and Apotek 1 -- rank among
the top 10% of all Norwegian companies. Research indicates this confidence is
a result of the expertise, customer service and information regarding
medicines provided by the pharmacies. Since the reform in pharmacy retailing
in 2001, pharmacy chains have upgraded their product assortment, locations and
services to better address their customer needs, while retaining their
competence as medical advisors. The deregulated retail environment continues
to attract new entrants to Norway with Boots as the latest arrival. Boots
opened it first outlet in February 2008 in Lillestrøm and plans to rollout an
additional 130 outlets within five years. Boots intends to differentiate the
new chain from rival pharmacy chains through offering a broad selection of
well-being products while retaining a focus on Rx and OTC medicines.
Moderate growth predicted over forecast period
In general, growth in constant value terms is expected to be slightly lower
over the forecast period than the review period. OTC healthcare prices
declined further in 2008 as the share of grocery store distribution increased
due to liberalisation. Overall, this trend had a negative impact on value
growth. However, the ageing Norwegian population will continue to consume
preventative remedies as well as OTC medications to help them remain active
throughout their senior years.
Table of Contents
- OTC HEALTHCARE IN NORWAY : MARKET INSIGHT
- EXECUTIVE SUMMARY
- OTC healthcare market characterised by preventative and simple remedies
- Marketing plays critical role in selling products
- Fragmentation characterises competitive environment
- Pharmacies develop loyal and satisfied customer base
- Moderate growth predicted over forecast period
- KEY TRENDS AND DEVELOPMENTS
- Brand dynamics become more important
- Pharmacies have loyal and satisfied customers
- Debate continues regarding price sensitivity of OTC healthcare products
- Norwegians more open to self-medication
- Online shopping on the horizon
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services
2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- MARKET DATA
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
- Table 8 Sales of OTC Healthcare by Sector and Distribution Format: %
Analysis 2008
- Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth
2008-2013
- APPENDIX
- OTC Registration and Classification
- De-listing or de-reimbursement
- Advertising
- Packaging and labelling
- Distribution
- Vitamins & Dietary Supplements Registration and Classification
- Self-medication and Preventative Medicine
- Generics
- Switches
- Summary 1 OTC Healthcare Switches 2006-2008
- DEFINITIONS
- Summary 2 Research Sources
- LOCAL COMPANY PROFILES - NORWAY
- AXELLUS AS - OTC HEALTHCARE - NORWAY
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 3 Axellus AS : Key Facts
- Summary 4 Axellus AS: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 5 Axellus AS: Production Statistics 2007
- COMPETITIVE POSITIONING
- Summary 6 Axellus AS: Competitive Position 2008
- BRYNILD GRUPPEN AS - OTC HEALTHCARE - NORWAY
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 7 Brynild Gruppen AS: Key Facts
- Summary 8 Brynild Gruppen AS: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 9 Brynild Gruppen AS : Competitive Position 2008
- MIDELFART SONESSON AS - OTC HEALTHCARE - NORWAY
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 10 Midelfart Sonesson AS: Key Facts
- Summary 11 Midelfart Sonesson AS: Operational Indicators
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- Summary 12 Midelfart Sonesson AS: Competitive Position 2008
- NYCOMED PHARMA AS - OTC HEALTHCARE - NORWAY
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 13 Nycomed Pharma AS: Key Facts
- Summary 14 Nycomed Pharma AS: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 15 Nycomed Pharma AS: Production Statistics 2007
- COMPETITIVE POSITIONING
- Summary 16 Nycomed Pharma AS: Competitive Position 2008
- WEIFA AS - OTC HEALTHCARE - NORWAY
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 17 Weifa AS: Key Facts
- Summary 18 Weifa AS: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 19 Weifa AS: Production Statistics 2007
- COMPETITIVE POSITIONING
- Summary 20 Weifa AS: Competitive Position 2008
- ANALGESICS IN NORWAY
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 11 Sales of Analgesics by Subsector: Value 2003-2008
- Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
- Table 13 Herbal vs Standard Topical Analgesics 2003-2008
- Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
- Table 15 Analgesics Company Shares by Value 2004-2008
- Table 16 Analgesics Brand Shares by Value 2005-2008
- Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
- Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth
2008-2013
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NORWAY
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: Value 2003-2008
- Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: % Value Growth 2003-2008
- Table 21 Sales of Decongestants by Type: Value 2003-2008
- Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 23 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies
2003-2008
- Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by
Value 2004-2008
- Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by
Value 2005-2008
- Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: Value 2008-2013
- Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: % Value Growth 2008-2013
- DIGESTIVE REMEDIES IN NORWAY
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 28 Sales of Digestive Remedies by Subsector: Value 2003-2008
- Table 29 Sales of Digestive Remedies by Subsector: % Value Growth
2003-2008
- Table 30 Herbal vs Standard Digestive Remedies 2003-2008
- Table 31 Digestive Remedies Company Shares by Value 2004-2008
- Table 32 Digestive Remedies Brand Shares by Value 2005-2008
- Table 33 Forecast Sales of Digestive Remedies by Subsector: Value
2008-2013
- Table 34 Forecast Sales of Digestive Remedies by Subsector: % Value
Growth 2008-2013
- MEDICATED SKIN CARE IN NORWAY
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 35 Sales of Medicated Skin Care by Subsector: Value 2003-2008
- Table 36 Sales of Medicated Skin Care by Subsector: % Value Growth
2003-2008
- Table 37 Acne Treatments by Format: % Value Breakdown 2004-2008
- Table 38 Medicated Skin Care Company Shares by Value 2004-2008
- Table 39 Medicated Skin Care Brand Shares by Value 2005-2008
- Table 40 Acne Treatments Brand Shares by Value 2005-2008
- Table 41 Hair Loss Treatments Brand Shares by Value 2005-2008
- Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value
2008-2013
- Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value
Growth 2008-2013
- VITAMINS AND DIETARY SUPPLEMENTS IN NORWAY
- HEADLINES
- TRENDS -- VITAMINS AND DIETARY SUPPLEMENTS
- Table 44 Penetration of Vitamins (Pills and Liquid Formats), Cod Liver
Oil and Natural Remedies for Total Population
- Table 45 High Frequency Users (More Than Five Times Weekly) of Vitamins
(Pills and Liquid Formats), Cod Liver Oil and Natural
- Remedies by Age Group abl
- TRENDS -- VITAMINS
- TRENDS -- DIETARY SUPPLEMENTS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 46 Dietary Supplements: Brand Ranking by Positioning
- SECTOR DATA
- Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value
2003-2008
- Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value
Growth 2003-2008
- Table 49 Folic Acid v Other B Vitamins 2004-2008
- Table 50 Dietary Supplements by Positioning 2006-2008
- Table 51 Vitamins and Dietary Supplements Company Shares by Value
2004-2008
- Table 52 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
- Table 53 Vitamins Brand Shares by Value 2005-2008
- Table 54 Dietary Supplements Brand Shares by Value 2005-2008
- Table 55 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: Value 2008-2013
- Table 56 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: % Value Growth 2008-2013
- NRT SMOKING CESSATION AIDS IN NORWAY
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR INDICATORS
- Table 57 Number of Smokers by Gender 2003-2008
- SECTOR DATA
- Table 58 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
- Table 59 Sales of Smoking Cessation Aids by Subsector: % Value Growth
2003-2008
- Table 60 NRT Gum Flavours: % Value Breakdown 2006-2008
- Table 61 Smoking Cessation Aids Company Shares by Value 2004-2008
- Table 62 Smoking Cessation Aids Brand Shares by Value 2005-2008
- Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value
2008-2013
- Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value
Growth 2008-2013
- EYE CARE IN NORWAY
- SECTOR DATA
- Table 65 Sales of Eye Care by Subsector: Value 2003-2008
- Table 66 Sales of Eye Care by Subsector: % Value Growth 2003-2008
- Table 67 Standard Eye Care by Type: % Value Breakdown 2007-2008
- Table 68 Eye Care Company Shares by Value 2004-2008
- Table 69 Eye Care Brand Shares by Value 2005-2008
- Table 70 Forecast Sales of Eye Care by Subsector: Value 2008-2013
- Table 71 Forecast Sales of Eye Care by Subsector: % Value Growth
2008-2013
- EAR CARE IN NORWAY
- SECTOR DATA
- Table 72 Sales of Ear Care: Value 2003-2008
- Table 73 Sales of Ear Care: % Value Growth 2003-2008
- Table 74 Ear Care Company Shares by Value 2004-2008
- Table 75 Ear Care Brand Shares by Value 2005-2008
- Table 76 Forecast Sales of Ear Care: Value 2008-2013
- Table 77 Forecast Sales of Ear Care: % Value Growth 2008-2013
- ADULT MOUTH CARE IN NORWAY
- HEADLINES
- SECTOR DATA
- Table 78 Sales of Adult Mouth Care: Value 2003-2008
- Table 79 Sales of Adult Mouth Care: % Value Growth 2003-2008
- Table 80 Adult Mouth Care Company Shares by Value 2004-2008
- Table 81 Adult Mouth Care Brand Shares by Value 2005-2008
- Table 82 Forecast Sales of Adult Mouth Care: Value 2008-2013
- Table 83 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
- CALMING AND SLEEPING PRODUCTS IN NORWAY
- SECTOR DATA
- Table 84 Sales of Calming and Sleeping Products: Value 2003-2008
- Table 85 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
- Table 86 Calming and Sleeping Products Company Shares by Value 2004-2008
- Table 87 Calming and Sleeping Products Brand Shares by Value 2005-2008
- Table 88 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
- Table 89 Forecast Sales of Calming and Sleeping Products: % Value Growth
2008-2013
- WOUND TREATMENTS IN NORWAY
- SECTOR DATA
- Table 90 Sales of Wound Treatments by Subsector: Value 2003-2008
- Table 91 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
- Table 92 Wound Treatments Company Shares by Value 2004-2008
- Table 93 Wound Treatments Brand Shares by Value 2005-2008
- Table 94 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
- Table 95 Forecast Sales of Wound Treatments by Subsector: % Value Growth
2008-2013
- EMERGENCY CONTRACEPTION IN NORWAY
- SECTOR DATA
- Table 96 Sales of Emergency Contraception: Value 2003-2008
- Table 97 Sales of Emergency Contraception: % Value Growth 2003-2008
- Table 98 Emergency Contraception Company Shares by Value 2004-2008
- Table 99 Emergency Contraception Brand Shares by Value 2005-2008
- Table 100 Forecast Sales of Emergency Contraception: Value 2008-2013
- Table 101 Forecast Sales of Emergency Contraception: % Value Growth
2008-2013
